Skip to content

There. You're smarter.

  • Articles
  • SmartPill
  • FastPoll
  • HealthyDose
  • Contact Us
  • About InsightCity
  • Search

SmartPill™ for the Week of February 26, 2018

Posted on February 25, 2018February 26, 2018Author 9586wpczarCategories SmartPill™ of the WeekTags biopharma, research, research funding

R&D ROI:

Source: Deloitte

Related

Post navigation

Previous Previous post: FastPoll™ for the Week of February 19, 2018
Next Next post: Marijuana Mythbusting

Sign up for our newsletter

FastPoll™ for the Week of May 7, 2018

When is the last time you ate something from a fast food restaurant? No fibbing.

  • FastPoll™ for the Week of May 7, 2018
    When is the last time you ate something from a fast food restaurant? No fibbing. […]
  • FastPoll™ for the Week of April 30, 2018
    Does your company currently have open US Pediatric Research Equity Act (PREA) or European […]
  • FastPoll™ for the Week of April 23, 2018
    Another week, another regulation question. Should there be a law that forces innovators to provide […]
  • FastPoll™ for the Week of April 16, 2018
    Speaking of unauthorized data sales and near-monopolies, do you think Facebook should face […]
  • FastPoll™ for the Week of April 9, 2018
    Would a cancer warning label on coffee change your coffee consumption? […]

Tags

AbbVie addiction adherence advertising Aetna alcohol allergan Alzheimer’s disease Amazon Amgen antibiotic resistance antibiotics Apple apps AstraZeneca bacteria biologics biopharma biosimilars biotech breast cancer Brexit cancer CAR-T Celgene China clinical research clinical trials CRISPR data depression diabetes diet direct to consumer drug approvals drug development Drug Pricing electronic health records Eli Lilly emergency department ethics exercise FDA fitness generics gene therapy genetics GSK health healthcare healthcare costs heart disease HIV hospitals immunotherapy influenza Innovation insurance lawsuits legislation M&A malaria manufacturing marketing medical device Medicare mental health Merck Mylan NHS NICE NIH Novartis obesity oncology opioids orphan drugs overdose patients pfizer pharma pharmacy Phase I physicians pregnancy prescriptions pricing public health regulation regulatory research Sanofi sleep smoking social media stem cells stroke technology Teva Trump UK vaccines wearables weight loss WHO youth zika

Sign up for updates

Contact us

[email protected] | 919-230-6767
Theme: Maisha Lite designed by Anariel Design.